CD4+ T-cell Activation Impairs Serogroup C Neisseria Meningitis Vaccine Response in HIV-infected Children
Overview
Authors
Affiliations
Objective: To investigate the influence of CD4 T-cell activation and regulatory populations in HIV-infected children antibody response to vaccination with a conjugate C polysaccharide vaccine.
Design: CD4 T-cell activation was evaluated by expression of CD38, HLA-DR and CCR5 molecules. Regulatory CD4 T cells (TReg) were characterized as FoxP3CD127CD25 and inducer T cells (TInd) as CD4FoxP3CD25CD39.
Methods: All patients (n = 36) were HIV-vertically infected, aged 2-17 years-old and were vaccinated with one vaccine injection. Blood samples were obtained before and after immunization to determine bactericidal antibody titers (SBA), CD4 T-cell activation and frequency of TReg and TInd subsets (multiparametric flow cytometry).
Results: Children not-responding (n = 18) to MenC vaccine expressed higher frequency of activated CD4 T cells (HLA-DRCD38CCR5) than responders (n = 18), both before and after vaccination (P < 0.05). A significant higher frequency of TReg was detected in responders compared with nonresponders (P = 0.0001). We also detected an inverse correlation between CD4DRCD38CCR5 (P = 0.01) or CD4DRCD38 (P = 0.02) T cells and TReg cell frequency after vaccination. CD4 T-cell activation negatively correlated (P = 0.006) with postvaccination SBA titers but a positive correlation (P = 0.0001) was detected between TReg cells and SBA. TReg and TInd subsets were inversely correlated (P = 0.04).
Conclusion: Our findings suggest that higher CD4 T-cell activation leads to poor vaccine response in children living with HIV, which may be associated with a TReg/TInd disequilibrium.
Pereira-Manfro W, Silva G, Costa P, Costa D, Ferreira B, Barreto D Rev Inst Med Trop Sao Paulo. 2023; 65:e14.
PMID: 36753067 PMC: 9901578. DOI: 10.1590/S1678-9946202365014.
Silva G, Pereira-Manfro W, Costa P, Costa D, Ferreira B, Barreto D Clinics (Sao Paulo). 2021; 76:e2902.
PMID: 34614112 PMC: 8449930. DOI: 10.6061/clinics/2021/e2902.
Milagres L, Silva G, Pereira-Manfro W, Frota A, Hofer C, Ferreira B Front Immunol. 2018; 9:2500.
PMID: 30420858 PMC: 6215828. DOI: 10.3389/fimmu.2018.02500.
Tozetto-Mendoza T, de Moraes Vasconcelos D, Ibrahim K, Sartori A, Bezerra R, de Freitas V Clinics (Sao Paulo). 2017; 72(11):652-660.
PMID: 29236910 PMC: 5706062. DOI: 10.6061/clinics/2017(11)02.
CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients.
Avelino-Silva V, Miyaji K, Hunt P, Huang Y, Simoes M, Lima S PLoS Negl Trop Dis. 2016; 10(12):e0005219.
PMID: 27941965 PMC: 5179051. DOI: 10.1371/journal.pntd.0005219.